Stock Symbol
688617.SH
Stock Symbol
688617.SH
Founded in
Listed in
CAGR-4 years
Countries
APT established in 2002 and listed on the STAR Board of Shanghai Stock Exchange in 2021, is a leading manufacturer and supplier of EP and Vascular Intervention medical devices, is committed to advancing the interventional medical field utilizing technologies and innovations. APT's growing product portfolio covers Electrophysiology, Cardiology, Peripheral, and Neuro intervention.
READ MORE
EuroPCR2021 kicked off productive discussions on CTO strategy on May 18th, APT is honored to participate in this world-leading course in interventional cardiovascular medicine.
READ MOREA clinical case is presented with a bilateral distal radial approach and successful treatment of chronic coronary occlusion through APT thin-walled 7F introducers
2021-05-02APT Medical hosted its first Latin America focused webinar: New Insights into Cardiovascular Latin America Perspective on March 26th 2021.
2021-04-18APT Medical’s opening online symposium in 2021, CollecTiOn: Sharing Expertise from West through East, was successfully held on February 4th, 2021.
2021-02-04
CTO cases and techniques sharing through West and East
New Insights Into Cardiovascular Intervention - Latin America Perspective
Spot on Youth #2 EP Webinar
Electrophysiology
Interventional Cardiology
Peripheral Intervention
APT Medical OEM/ODM
